(Q68202658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Phase I study of Datelliptium chloride, hydrochloride given by 24-h continuous intravenous infusion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

D Khayat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

C Borel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

M Azab

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

D Paraisot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

E Malaurie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

C Bouloux

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

M Weil

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

22 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

226-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00686318

22 September 2019

exact match

0 references

cites work

Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417.

1 reference

12 December 2020

2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)

1 reference

12 December 2020

Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage

1 reference

12 December 2020

Alkaloids of Ochrosia maculata Jacq. (Ochrosia borbonica Gmel.). Isolation of the alkaloids and study of the antitumor properties of 9-methoxyellipticine

1 reference

12 December 2020

A New Antitumoral Agent: 9-Hydroxyellipticine. Possibility of a Rational Design of Anticancerous Drugs in the Series of DNA Intercalating Drugs

1 reference

12 December 2020

Elliptinium acetate in metastatic breast cancer--a phase II study

1 reference

12 December 2020

Elliptinium: phase II study in advanced measurable breast cancer

1 reference

12 December 2020

Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.

1 reference

12 December 2020

Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1628372%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference